Induction of a hypertrophic growth status of coronary smooth muscle cells is associated with an overexpression of TGF-β

This publication has 15 references indexed in Scilit:

• TGF-βs and TGF-β receptors in atherosclerosis
  Cytokine & Growth Factor Reviews, 2000
• Mechanical Load Opposes Angiotensin-Mediated Decrease in Vascular α₁-Adrenoceptors
  Hypertension, 1997
• Modulation of fibroblast growth factor-2 receptor binding, dimerization, signaling, and angiogenic activity by a synthetic heparin-mimicking polyanionic compound.
  Journal of Clinical Investigation, 1997
• Differential Roles of AT ₁ and AT ₂ Receptor Subtypes in Vascular Trophic and Phenotypic Changes in Response to Stimulation With Angiotensin II
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
• In vitroandin vivoeffects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation
  British Journal of Pharmacology, 1997
• Heparin-Induced Overexpression of Basic Fibroblast Growth Factor, Basic Fibroblast Growth Factor Receptor, and Cell-Associated Proteoheparan Sulfate in Cultured Coronary Smooth Muscle Cells
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1996
• Antiproliferative activity to vascular smooth muscle cells and receptor binding of heparin-mimicking polyaromatic anionic compounds.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
• Protection of transforming growth factor β activity by heparin and fucoidan
  Journal of Cellular Physiology, 1994
• Mimicry of Biological Macromolecules by Polyaromatic Anionic Compounds
  Journal of Bioactive and Compatible Polymers, 1993
• Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2-macroglobulin inactive complex.
  The Journal of cell biology, 1989